Avacta is an England-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
Business Model:
Revenue: $4M
Employees: 51-200
Address: Ash Way
City: Wetherby
State: england
Zip: LS23 7FA
Country: GB
Avacta is an England-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
Contact Phone:
Contact Email:
Listed Exchange:
London Stock Exchange
IPO Date:
9/25/2003
Ticker Symbol:
AVCT
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2022 | AffyXell Therapeutics | Corporate Round | - |
4/2022 | AffyXell Therapeutics | Corporate Round | - |
Announced Date | Name | Price |
---|---|---|
1/2012 | Aptuscan | |
1/2010 | ReactivLab | |
3/2009 | Curidium Medica | |
2/2009 | Avacta Animal Health | |
1/2009 | TheraGenetics | |
11/2007 | Oxford Medical Diagnostics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|